Our Consortium

ROAR (Rare Organic Acidemias Research) is a multi‑center study that brings together patients, families, clinicians, and researchers to better understand rare organic acidemias such as PA, MMA, GA‑1, IVA, and others. Our goal is to improve lifelong care and future treatment options for the rare disease community.

ROAR works in partnership with patient organizations, clinicians, and research networks to ensure that study findings are shared, accessible, and meaningful. Families play a central role in shaping our questions and informing our direction.